Hospital Pharmacy - July/August 2017 - 477

477

Ubaka et al
has helped reduce cases of understocking and overstocking,
and the overuse of nonformulary drugs that is evident in tertiary level hospitals in Nigeria. Pharmacists need to take
charge in revitalizing the weak efforts of the Pharmacy and
Therapeutics Committees in their hospitals and meet regularly (at least once in 2 months) to review new and outdated/
ineffective medicines within the hospital's supply chain.
C.U. observed the stages of implementation of the antibiotic
stewardship program at the OSU, and thus he can adopt such
a mechanism back in hospitals in Nigeria, even though there
is paucity of ID-trained specialists or pharmacists. The OSU
mentor took C.U. through the different components of the
ASP and discussed valid ways of implementing them in
view of a system with limited resources. C.U.'s experience
with Twitter and its ability to achieve a global impact has
connected him with pharmacist specialists, ID physicians,
and other health practitioners. Resources and discussions on
implementing current guidelines on ID have been mutually
shared and have benefited all.
The pharmacy leadership team benefitted greatly from
the Mandela Fellowship. First the fellowship provided an
in-depth look at health care in an African country-something that none of the leadership team had experience. In
addition, it was surprising to see that pharmacy was a very
close-knit community-all experiencing the same problems, aspirations, and goals for growth and excellence.
Finally, the administrative time spent with the program was
minimal-and truly counted on the organizational skills of a
few people who helped to coordinate meetings, and schedule project time and observational experiences for C.U.

Conclusions
Major global challenges exist in the profession of pharmacy and pharmacy practice. A possible root cause could
be that the current educational structure may not be meeting
the needs of a nation's health care. It is important for pharmacy leaders and schools of pharmacy in the United States
to collaborate with the international community to influence and accelerate the growth of their practice model. The
experience with Nigeria through the MWF program is one
example of how pharmacy leaders can collaborate and
establish international ties within health-system pharmacy.
As a component of the MWF program, the pharmacy-mentoring program allowed C.U. to experience firsthand the
impact pharmacists make on patient care. Many insights
were gained from the cross collaboration between C.U. and
D.G., and a lifelong professional and personal relationship
has also been forged. These types of programs represent
leadership opportunities that may not be apparent to most
pharmacy directors, but expanding their view to helping
international pharmacists expand their practice only
strengthens the professional goal of providing patient-centered pharmacy services.

Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.

Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.

References
1. Manasse HR. Perspectives on the global evolution and development of pharmacy. Am J Health Syst Pharm. 2013;70:675-679.
2. https.//www.whitehouse.gov/the-press-office/2014/07/28/factsheet-mandela-washington-fellowship-young-african-leaders.
Accessed July 27, 2016
3. Olurinola PF. The pharmacy profession: a focus on Nigeria.
Zaria, Nigeria: Excel Publishing; 2003.
4. Ohuabunwa M. Health care delivery in Nigeria: Past present
and the future. NigJ Pharm. 2002;31:15-17.
5. Aluko SO. Death for sale: A case study of drug poisoning and
deaths in Nigeria. Soc Sci Med. 1994;38(l):97.
6. Erhun WO, Babalol OO, Erhun MO. Drug regulation and control in Nigeria: the challenge of counterfeit drugs. J Health
Popul Dev Ctries. 2001;4(2):23-34.
7. US Food and Drug Administration. Drug supply chain
integrity [Internet]. US Department of Health and
Human Services. http://www.fda.gov/Drugs/DrugSafety/
DrugIntegrityandSupplyChainSecurity/. Published July 6,
2015. Accessed June 24, 2017
8. Brechtelsbauer E, Pennell B, Durham M, Hertig J, Weber R.
Review of the 2015 Drug Supply Chain Security Act. Hosp
Pharm. 2016;51(6):493-500.
9. Ubaka CM, Ekwunife OI, Adibe MO. Does the clinical clerkship course improve students' attitudes towards pharmaceutical care? Int J Pharm Pract. 2012;20:272-274.
10. Ubaka CM, Ochie UM, Adibe MO. Student pharmacists'
career choices: a survey of three Nigerian schools of pharmacy.
Pharm Pract. 2013;11(3):149-155.
11. Tertiary Education Trust Fund-University of Nigeria Research
Grant. Trends and determinants of the geographical and sectoral profile of the Nigerian Pharmacist Workforce (Dr. Ubaka
Chukwuemeka (Grantee)). www.tetfund.unn.edu.ng/research.
Assessed July 20, 2016
12. Jordan T, et al. Elevating pharmacists' scope of practice through
a health-system clinical privileging process. Am J Health Syst
Pharm. 2016;73:e513-523. doi:10.2146/ajhp150820.
13. Goff D, File TM. The evolving role of antimicrobial stewardship in management of multidrug resistant infections. Infect Dis
Clin N Am. 2016;30:539-551. doi:10.1016/j.idc.2016.02.012
14. Goff DA, Bauer KA, Reed EE, et al. Is the "low-hanging fruit"
worth picking for antimicrobial stewardship programs? Clin
Infect Dis. 2012;55:587-592.
15. Brink A, Messina A, Feldman C, et al. Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet. 2016;16(9):1017-1025. doi.10.1016/
S1473-S3099.(16)30012-3
16. http://www.symplur.com/healthcare-hashtags/mwf2016/.
Accessed on July 27. 2016.


https://www.whitehouse.gov/the-press-office/2014/07/28/fact-sheet-mandela-washington-fellowship-young-african-leaders https://www.whitehouse.gov/the-press-office/2014/07/28/fact-sheet-mandela-washington-fellowship-young-african-leaders http://www.fda.gov/Drugs/DrugSafety/DrugIntegrityandSupplyChainSecurity/ http://www.fda.gov/Drugs/DrugSafety/DrugIntegrityandSupplyChainSecurity/ http://www.tetfund.unn.edu.ng/research http://www.symplur.com/healthcare-hashtags/mwf2016/

Table of Contents for the Digital Edition of Hospital Pharmacy - July/August 2017

The Evolution of Drug Information Centers and Specialists
Letter: Sodium Phosphates Injection—Osmolarity Labeling Correction
ISMP Adverse Drug Reactions
Drug Monographs: Avelumab and Ribociclib
Formulary Drug Review: Naldemedine
Chimeric Antigen Receptor T-Cell Therapy for Lymphomas: A Review of a Drug Class or Therapeutic Class in a Late Stage of Clinical Development
International Mentoring Programs: Leadership Opportunities to Enhance Worldwide Pharmacy Practice
Compounded Apixaban Suspensions for Enteral Feeding Tubes
Impact of Developing Adult Ketamine Order Panels for the Emergency Department
Critical Appraisal of Biomedical Literature With a Succinct Journal Club Template: The ROOTs Format
Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial
Examining the Use of Sodium Nitroprusside in Coronary Artery Bypass Grafting: Is the Benefit Worth the Cost?
Successful Implementation of an Antimicrobial Stewardship Program at an Academic Medical Center
Hospital Pharmacy - July/August 2017 - 445
Hospital Pharmacy - July/August 2017 - 446
Hospital Pharmacy - July/August 2017 - 447
Hospital Pharmacy - July/August 2017 - 448
Hospital Pharmacy - July/August 2017 - 449
Hospital Pharmacy - July/August 2017 - 450
Hospital Pharmacy - July/August 2017 - 451
Hospital Pharmacy - July/August 2017 - The Evolution of Drug Information Centers and Specialists
Hospital Pharmacy - July/August 2017 - 453
Hospital Pharmacy - July/August 2017 - Letter: Sodium Phosphates Injection—Osmolarity Labeling Correction
Hospital Pharmacy - July/August 2017 - ISMP Adverse Drug Reactions
Hospital Pharmacy - July/August 2017 - 456
Hospital Pharmacy - July/August 2017 - 457
Hospital Pharmacy - July/August 2017 - 458
Hospital Pharmacy - July/August 2017 - Drug Monographs: Avelumab and Ribociclib
Hospital Pharmacy - July/August 2017 - 460
Hospital Pharmacy - July/August 2017 - 461
Hospital Pharmacy - July/August 2017 - 462
Hospital Pharmacy - July/August 2017 - 463
Hospital Pharmacy - July/August 2017 - Formulary Drug Review: Naldemedine
Hospital Pharmacy - July/August 2017 - 465
Hospital Pharmacy - July/August 2017 - 466
Hospital Pharmacy - July/August 2017 - 467
Hospital Pharmacy - July/August 2017 - 468
Hospital Pharmacy - July/August 2017 - Chimeric Antigen Receptor T-Cell Therapy for Lymphomas: A Review of a Drug Class or Therapeutic Class in a Late Stage of Clinical Development
Hospital Pharmacy - July/August 2017 - 470
Hospital Pharmacy - July/August 2017 - International Mentoring Programs: Leadership Opportunities to Enhance Worldwide Pharmacy Practice
Hospital Pharmacy - July/August 2017 - 472
Hospital Pharmacy - July/August 2017 - 473
Hospital Pharmacy - July/August 2017 - 474
Hospital Pharmacy - July/August 2017 - 475
Hospital Pharmacy - July/August 2017 - 476
Hospital Pharmacy - July/August 2017 - 477
Hospital Pharmacy - July/August 2017 - Compounded Apixaban Suspensions for Enteral Feeding Tubes
Hospital Pharmacy - July/August 2017 - 479
Hospital Pharmacy - July/August 2017 - 480
Hospital Pharmacy - July/August 2017 - 481
Hospital Pharmacy - July/August 2017 - 482
Hospital Pharmacy - July/August 2017 - Impact of Developing Adult Ketamine Order Panels for the Emergency Department
Hospital Pharmacy - July/August 2017 - 484
Hospital Pharmacy - July/August 2017 - 485
Hospital Pharmacy - July/August 2017 - 486
Hospital Pharmacy - July/August 2017 - 487
Hospital Pharmacy - July/August 2017 - Critical Appraisal of Biomedical Literature With a Succinct Journal Club Template: The ROOTs Format
Hospital Pharmacy - July/August 2017 - 489
Hospital Pharmacy - July/August 2017 - 490
Hospital Pharmacy - July/August 2017 - 491
Hospital Pharmacy - July/August 2017 - 492
Hospital Pharmacy - July/August 2017 - 493
Hospital Pharmacy - July/August 2017 - 494
Hospital Pharmacy - July/August 2017 - 495
Hospital Pharmacy - July/August 2017 - Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial
Hospital Pharmacy - July/August 2017 - 497
Hospital Pharmacy - July/August 2017 - 498
Hospital Pharmacy - July/August 2017 - 499
Hospital Pharmacy - July/August 2017 - 500
Hospital Pharmacy - July/August 2017 - 501
Hospital Pharmacy - July/August 2017 - Examining the Use of Sodium Nitroprusside in Coronary Artery Bypass Grafting: Is the Benefit Worth the Cost?
Hospital Pharmacy - July/August 2017 - 503
Hospital Pharmacy - July/August 2017 - 504
Hospital Pharmacy - July/August 2017 - 505
Hospital Pharmacy - July/August 2017 - 506
Hospital Pharmacy - July/August 2017 - 507
Hospital Pharmacy - July/August 2017 - Successful Implementation of an Antimicrobial Stewardship Program at an Academic Medical Center
Hospital Pharmacy - July/August 2017 - 509
Hospital Pharmacy - July/August 2017 - 510
Hospital Pharmacy - July/August 2017 - 511
Hospital Pharmacy - July/August 2017 - 512
Hospital Pharmacy - July/August 2017 - 513
Hospital Pharmacy - July/August 2017 - 514
Hospital Pharmacy - July/August 2017 - 515
Hospital Pharmacy - July/August 2017 - 516
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com